CCL3 contributes to secondary damage after spinal cord injury

por Pelisch, Nicolas, Rosas Almanza, Jose, Stehlik, Kyle E., Aperi, Brandy V., Kroner, Antje
Publicado 2020

Use of a Self-Delivering Anti-CCL3 FANA Oligonucleotide as an Innovative Approach to Target Inflammation after Spinal Cord Injury

por Pelisch, Nicolas, Rosas Almanza, Jose, Stehlik, Kyle E., Aperi, Brandy V., Kroner, Antje
Publicado 2021

Correction to: CCL3 contributes to secondary damage after spinal cord injury

por Pelisch, Nicolas, Almanza, Jose Rosas, Stehlik, Kyle E., Aperi, Brandy V., Kroner, Antje
Publicado 2021

Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis

por Pelisch, Nicolas, Dan, Takashi, Ichimura, Atsuhiko, Sekiguchi, Hiroki, Vaughan, Douglas E., van Ypersele de Strihou, Charles, Miyata, Toshio
Publicado 2015